Simeprevir + Sofosbuvir

Grey

Brand Name(s):Olysio + Sovaldi

Indication:Hepatitis C (chronic) – genotype 1 and 4

Rationale:2

Considered:Jun-14

Review Date:Nov-20

Comments:
NICE TA 361

NICE is unable to make a recommendation about the use in the NHS of simeprevir in combination with sofosbuvir for treating genotype 1 or 4 chronic hepatitis C because no evidence submission was received from Janssen for the technology.

https://www.nice.org.uk/guidance/ta361

Nov 2015